Active substanceChondroitin sulfateChondroitin sulfate
Similar drugsTo uncover
  • Artogistan
    solution w / m 
    GROTEKS, LLC     Russia
  • ARTRA® Chondroitin
    capsules inwards 
    Unipharm, Inc.     USA
  • Arthravir®-Inkamparm®
    solution w / m 
    TRIVIUM-XXI, LLC     Russia
  • Arthradol®
    lyophilizate w / m 
    Inkamfarm, OOO     Russia
  • ARTRADOL®
    capsules inwards 
    TRIVIUM-XXI, LLC     Russia
  • Artrafic
    ointment externally 
    ATOLL, LLC     Russia
  • DRASTOP
    solution w / m 
  • Mukosat®
    solution w / m 
  • Mukosat®
    ointment externally 
       
  • Teraflex® Hondrokrem Forte
    cream externally 
    BAYER, AO     Russia
  • Hondroguard®
    solution w / m 
  • Chondroitin
    capsules inwards 
    VERTEKS, AO     Russia
  • Chondroitin
    gel externally 
    VERTEKS, AO     Russia
  • Chondroitin
    capsules inwards 
    ATOLL, LLC     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
    ELLARA, LTD.     Russia
  • Chondroitin-Akos
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Chondroitin-Akos
    capsules inwards 
    SYNTHESIS, OJSC     Russia
  • Chondroitin sulfate
    solution w / m 
    Medimeks, ZAO     Russia
  • Chondroitin sulfate
    solution w / m 
    ELLARA, LTD.     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
  • Chondroitin sulfate
    solution w / m 
    BIOSINTEZ, PAO     Russia
  • Chondroxide®
    ointment externally 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    pills inwards 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    gel externally 
    NIZHFARM, JSC     Russia
  • Chondrolon®
    lyophilizate w / m 
  • Dosage form: & nbspcream for external use
    Composition:

    Active substances: chondroitin sodium sulfate - 50 mg, meloxicam - 10 mg;

    Excipients: dimethyl sulfoxide 100 mg, propylene glycol 100 mg, macrogol cetostearate 12 mg, cetostearyl alcohol [cetyl alcohol not more than 60%, stearyl alcohol at least 40%] 42 mg, paraffin liquid 100 mg, petrolatum 80 mg, imidourea, 3 mg, sodium disulfite - 0.5 mg, water - up to 1.00 g.

    Description:Cream from light yellow with a greenish tinge to a yellow with a greenish tint of color with the smell of dimethylsulfoxide.
    Pharmacotherapeutic group:Regeneration of tissue stimulant + non-steroidal anti-inflammatory drug
    ATX: & nbsp

    M.01.A.X.25   Chondroitin sulfate

    Pharmacodynamics:

    Chondroxide® Forte cream has a combined effect: it slows the progression of osteoarthritis and osteochondrosis, has an analgesic effect, promotes an increase in joint motion (in the area of ​​application of the cream), has anti-inflammatory action, reduces swelling of the joints.Due to the optimal combination of the components of the cream, there is a mutual enhancement of their analgesic and anti-inflammatory effects.

    Chondroitin sulfate - high molecular weight mucopolysaccharide, which is a natural component of cartilaginous tissue. Chondroitin sulfate improves the phosphorus-calcium metabolism in the cartilaginous tissue, inhibits enzymes that cause cartilage damage, inhibits degeneration (destruction) of the cartilaginous tissue, stimulates the synthesis of glycosaminoglycans, promotes the regeneration (restoration) of the cartilaginous surfaces of the joints, accelerates the repair of their repair, prevents the collapse of connective tissue. This leads to a decrease in soreness and increased mobility of the affected joints.

    Meloksikam - non-steroidal anti-inflammatory agent, has anti-inflammatory, analgesic effect. Meloksikam selectively inhibits cyclooxygenase 2, disrupts the metabolism of arachidonic acid, reduces the number of prostaglandins (mediators of pain and inflammation) in the inflammatory focus. Meloksikam is a chondrojetral drug, does not adversely affect cartilaginous tissue, does not affect the synthesis of proteoglycan by chondrocytes of articular cartilage.

    Indications:

    The drug is recommended for use in the complex therapy of degenerative-dystrophic diseases of the musculoskeletal system: osteoarthritis, osteochondrosis of the spine; Other joint diseases accompanied by pain syndrome.

    Contraindications:Hypersensitivity to the components of the drug (as well as to other non-steroidal anti-inflammatory drugs), violation of the integrity of the skin in places of presumed application, children's age (up to 12 years).
    Carefully:If the kidneys and liver function is impaired, with severe pathology of the gastrointestinal tract (peptic ulcer in the acute phase), with severe pathology of the blood system, the elderly.
    Pregnancy and lactation:The use of the drug is contraindicated during pregnancy and lactation.
    Dosing and Administration:Outwardly. Slightly rub strip of cream length from 1 to 5 cm, the frequency of application - 2-3 times a day. The required amount of the drug depends on the size of the painful area. After applying the product, the hands should be thoroughly washed. The duration of treatment depends on the indications and the effect observed.After 2 weeks of use, consult a physician.
    Side effects:There may be allergic reactions from the skin (itching, redness, skin rash). If there are any side effects, stop using the cream and consult a doctor.
    Overdose:Extremely low systemic absorption of active components of the drug with external application makes an overdose almost impossible.
    Interaction:Cases of interaction or incompatibility with other drugs are not described.
    Special instructions:
    The drug should be applied only to intact skin, avoiding getting on open wounds. Do not allow the product to get into the eyes and mucous membranes.
    You should consult your doctor before sharing the Chondroxide® Forte Cream with other non-steroidal anti-inflammatory drugs, and also if you need to use the drug for more than 2 weeks.
    Effect on the ability to drive transp. cf. and fur:The drug does not cause sedation, psychomotor disorders and does not affect the patient's ability to engage in potentially hazardous activities,requiring increased attention and speed of mental and motor reactions.
    Form release / dosage:Cream for external use, 1% + 5%.
    Packaging:
    By 10, 20, 25, 30, 50 or 100 g in the tubes are aluminum. Each tube together with instructions for the use of the drug is placed in a pack of cardboard.
    Storage conditions:At a temperature of no higher than 25 ° C. Keep out of the reach of children.
    Shelf life:2 years. Do not use the drug after the expiration date.
    Terms of leave from pharmacies:Without recipe
    Registration number:LP-000276
    Date of registration:17.02.2011 / 05.04.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:BAYER, AO BAYER, AO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp20.12.2017
    Illustrated instructions
      Instructions
      Up